A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is administered to reduce morbidity and mortality. Limited access to ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction ("PH-HFpEF"), supporting endpo ...

The data are observational but intuitive, say experts. Further work might define where T-TEER’s greatest benefit lies.

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

"AISAP is proud to collaborate with forward-thinking practices and community partners like Amavita," said Roni Attali, AISAP U.S. general manager and chief sales officer. "We commend Dr.

Differential diagnosis with arrhythmogenic right ventricular cardiomyopathy (ARVC ... p<0.0001), and RV fractional shortening and ejection fraction were significantly lower in ARVC patients compared ...

Cedars-Sinai shared the story of a Hollywood writer who kept his appointment for mitral valve surgery right ... ventricular volume and function, save for small drops in left ventricular ejection ...

Spire Wealth Management bought a new position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) in the fourth quarter, ...

HC Wainwright reissued their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report ...

left ventricular ejection fraction; RV, right ventricular; RVEDV, right ventricular end-diastolic volume; RVESV, right ventricular end-systolic volume; RVEF, right ventricular ejection fraction; ...